We focused our research on the characterization of caffeine as a potential treatment and elucidated how caffeine affects the AMPK/mTOR pathway as a potential target for the neuroprotective effect observed after treatment in a neonatal hypoxia-ischemia model. This evidence concerns the gene MTOR and ischemia.